Edward A. Taylor

Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy

Chemokine Therapeutics Corp. is a biotechnology company, developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases. The company's product candidates in clinical trials include CTCE-0214, for enhancing the immune system; and CTCE-9908, to prevent the spread of cancer and its continued growth. Chemokine Therapeutics was founded on July 15, 1998 and is headquartered in Vancouver, Canada.

Exciton Technologies, Inc. operates as a Canadian materials research and development company that focuses on the creation of technologies for preventing and controlling infection. It offers exsalt SD7 wound dressing and exsalt T7 wound dressing. The company was founded by Rod Precht in 2010 and is headquartered in Edmonton, Canada.

Ceapro, Inc. is a canadian biotechnology company. The firm engages in the development and commercialization of active ingredients derived from oats and other renewable plant resources for healthcare and cosmetic industries. Its products include natural active ingredients, natural anti-aging skincare products, and veterinary therapeutic products. The company was founded on January 1, 1997 and is headquartered in Edmonton, Canada.

Financial Executives International enhances member professional development through peer networking, career planning services, conferences, publications and special reports, and research. Its members include Chief Financial Officers, Vice Presidents of Finance, Treasurers, and Controllers. The company was founded in December 1931 and is headquartered in Morristown, NJ.

Cascadian Therapeutics LLC is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutic products for the treatment of cancer. Its product ONT-380, is an orally active and selective small-molecule HER2 inhibitor. The firm also develops preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on September 7, 2007 and is headquartered in Bothell, WA.

Certified General Accountants Association of British Columbia is a non-profit company based in Vancouver, Canada. The CEO of the Canadian company is Gordon Ruth.